tradingkey.logo
tradingkey.logo
Search

Eikon Therapeutics Ord Shs

EIKN
Add to Watchlist
9.210USD
-0.410-4.26%
Close 07-31 16:00ETQuotes delayed by 15 min
498.62MMarket Cap
LossP/E TTM

EIKN Financials

See Eikon Therapeutics Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Eikon Therapeutics Ord Shs Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-2.46/-1.74
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-6.18
-36.84%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
Financial Indicators
EPS
---2.46
---1.48
----
Net Profit
---82.96M
---79.66M
----
Operating profit
---87.34M
---83.17M
----
Net Profit
---82.96M
---79.66M
----
Current assets
--529.50M
--348.92M
--390.50M
Total current liabilities
--45.06M
--55.01M
--44.39M
Total assets
--850.83M
--594.73M
--642.34M
Total liabilities
--300.15M
--312.30M
--285.22M
Total equity
--550.67M
--282.44M
--357.12M
Net operating income
---89.80M
---41.72M
----
Net investment
---203.22M
--40.71M
----
Net financing
--349.31M
--1.09M
----

FAQs

What are the current assets of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its current assets were 348.92M, with a year-on-year change of 53.11.

What are the total assets of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its total assets of Eikon Therapeutics Ord Shs were 594.73M, with a year-on-year change of 21.07.

What are the total liabilities of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its total liabilities of Eikon Therapeutics Ord Shs were 312.30M, with a year-on-year change of 22.49.

What is the total equity of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its total equity of Eikon Therapeutics Ord Shs was 282.44M, with a year-on-year change of 19.53.

What is the net operating income of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its net operating income of Eikon Therapeutics Ord Shs was -338.94M, with a year-on-year change of -30.19.

What is the net investment of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its net investment of Eikon Therapeutics Ord Shs was -181.34M, with a year-on-year change of -219.82.

What is the net financing of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its net financing of Eikon Therapeutics Ord Shs was 352.05M, with a year-on-year change of 144184.02.

What is the Earnings Per Share (EPS) of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -6.18, with a year-on-year change of -36.84.

What is the net income of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its net income was -333.64M, with a year-on-year change of -36.84.

What is the Return on Assets (ROA) of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -59.72, with a year-on-year change of -24.54.

What is the operating profit of Eikon Therapeutics Ord Shs?

According to Eikon Therapeutics Ord Shs's FY2025 earnings report, its operating profit was -338.94M, with a year-on-year change of -30.19.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.